Stock Analysis

Why Beter Bed Holding N.V. (AMS:BBED) Could Be Worth Watching

ENXTAM:BBED
Source: Shutterstock

Beter Bed Holding N.V. (AMS:BBED), is not the largest company out there, but it saw significant share price movement during recent months on the ENXTAM, rising to highs of €4.32 and falling to the lows of €3.11. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Beter Bed Holding's current trading price of €3.11 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Beter Bed Holding’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Beter Bed Holding

What's The Opportunity In Beter Bed Holding?

According to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 7.94x is currently trading slightly below its industry peers’ ratio of 9.23x, which means if you buy Beter Bed Holding today, you’d be paying a reasonable price for it. And if you believe Beter Bed Holding should be trading in this range, then there isn’t much room for the share price to grow beyond the levels of other industry peers over the long-term. Although, there may be an opportunity to buy in the future. This is because Beter Bed Holding’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What kind of growth will Beter Bed Holding generate?

earnings-and-revenue-growth
ENXTAM:BBED Earnings and Revenue Growth September 28th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with a negative profit growth of -2.5% expected over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Beter Bed Holding. This certainty tips the risk-return scale towards higher risk.

What This Means For You

Are you a shareholder? BBED seems priced close to industry peers right now, but given the uncertainty from negative returns in the future, this could be the right time to reduce the risk in your portfolio. Is your current exposure to the stock optimal for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on BBED, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on BBED for a while, now may not be the most advantageous time to buy, given it is trading around industry price multiples. This means there’s less benefit from mispricing. In addition to this, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help crystallize your views on BBED should the price fluctuate below the industry PE ratio.

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Case in point: We've spotted 2 warning signs for Beter Bed Holding you should be aware of.

If you are no longer interested in Beter Bed Holding, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Valuation is complex, but we're helping make it simple.

Find out whether Beter Bed Holding is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.